IABP Workshop
|
13:30-17:30 北辰 竹风厅 |
|---|
| 主持 Moderators | 邱原刚 Yuangang QIU, 胡武明 Wuming HU | ||
|
13:30-13:40 |
开场致辞 Opening Remarks |
||
|
13:40-14:10 |
心源性休克的定义及器械治疗 Definition of Cardiogenic Shock and Mechanical Circulatory Support |
俞章平 Zhangping YU | |
|
14:10-14:40 |
急性心肌梗死合并心源性休克诊断与治疗中国专家共识 Chinese Expert Consensus on Diagnosis and Treatment of Acute Myocardial Infarction Complicated with Cardiogenic Shock |
官学强 Xueqiang GUAN | |
|
14:40-15:10 |
IABP在高危PCI围术期的询证学依据 Evidence-based medical evidence of IABP in high-risk PCI |
张奇 Qi ZHANG | |
|
15:10-15:20 |
讨论 Discussion |
||
|
15:20-15:50 |
主动脉球囊反搏泵（IABP）的原理，置入时机及适用症 Principles, Timing of Implantation, and Indications of Intra-Aortic Balloon Pump (IABP) |
黄安安 Anan HUANG | |
|
15:50-16:20 |
IABP操作要点及并发症处理 IABP Insertion and Complication management |
高启跃 Qiyue GAO | |
|
16:20-16:50 |
IABP机器操作与报警处理（故障排除） IABP operation and troubleshooting |
吴伦哲 Lunzhe WU | |
|
16:50-17:10 |
病例1 IAB Case Sharing I |
黄安安 Anan HUANG | |
|
17:10-17:30 |
病例2 IAB Case Sharing II |
赵柯超 Kechao ZHAO | |
Artificial Intelligence Forum-1
|
13:30-15:30 北辰 竹风厅 |
|---|
| 主持 Moderators | 华军益 Junyi HUA, 官学强 Xueqiang GUAN, 相鹏 Peng XIANG, 赵炎波 Yanbo ZHAO | ||
|
13:30-13:50 |
多模态医学大模型统一理解与临床应用 Unified Understanding and Clinical Applications of Multimodal Medical Large Models |
吴健 Jian WU | |
|
13:50-14:10 |
DeepRETStroke：用眼底影像预测“隐匿性脑梗”与卒中风险（技术视角） DeepRETStroke: Predicting Covert Cerebral Infarction and Stroke Risk from Fundus Images (A Technical Perspective) |
盛斌 Bin SHENG | |
|
14:10-14:30 |
AI-CMR在心肌疾病综合判读与分型中的应用 The Role of AI-CMR in the Comprehensive Interpretation and Phenotyping of Myocardial Diseases |
赵世华 Shihua ZHAO | |
|
14:30-14:50 |
AI赋能心律失常诊治进展 Advances in Arrhythmia Diagnosis and Management Empowered by Artificial Intelligence |
张萍 Ping ZHANG | |
|
14:50-15:10 |
AI预测动脉粥样硬化斑块破裂的价值 The Value of AI in Predicting Atherosclerotic Plaque Rupture |
张金盈 Jinying ZHANG | |
|
15:10-15:30 |
讨论 Discussion |
||
Artificial Intelligence Forum-2
|
15:30-17:30 北辰 竹风厅 |
|---|
| 主持 Moderators | 张金盈 Jinying ZHANG, 李长岭 Changling LI, 戴能 Neng DAI, 朱齐丰 Qifeng ZHU, 李静 Jing LI | ||
|
15:30-15:50 |
AI仿真冠脉功能学评估 AI-Based Simulation for Coronary Functional Assessment |
李长岭 Changling LI | |
|
15:50-16:10 |
人工智能在心血管疾病和慢病诊断方面的一些应用 Applications of Artificial Intelligence in the Diagnosis of Cardiovascular and Chronic Diseases |
白晓宇 Xiaoyu BAI | |
|
16:10-16:30 |
血管介入机器人临床应用现状 Current Clinical Applications of Robotic Systems for Vascular Intervention |
王威 Wei WANG | |
|
16:30-16:50 |
心脏病学的数字创新—从数据科学到人工智能 Digital Innovation in Cardiology: From Data Science to Artificial Intelligence |
Toru SUZUKI | |
|
16:50-17:10 |
冠状动脉AI三维成像系统在复杂冠心病介入治疗中的应用 Application of an Artificial Intelligence-Based 3D Coronary Imaging System in Complex Coronary Intervention |
王定宇 Dingyu WANG | |
|
17:10-17:30 |
讨论：国际多中心协作与合规落地 Implementing Global Multicenter Collaboration Within Regulatory Frameworks |
||
Device Innovation Forum-1
|
08:00-10:00 北辰 竹风厅 |
|---|
| 主持 Moderators | 胡新央 Xinyang HU, 计剑 Jian JI, 黄楠 Nan HUANG | ||
| 讨论嘉宾 Discussants | 贺永 Yong HE, 宋雷 Lei SONG, 王建安 Jianan WANG | ||
|
08:00-08:20 |
生物材料设计促进心肌梗死后心脏构型重建 Positively Affecting Cardiac Wall Remodeling After Myocardial Infarction Through Rational Biomaterial Design |
William R. WAGNER | |
|
08:20-08:40 |
生物可吸收心血管植入器械 Research and Clinical Progress of Bioresorbable Cardiovascular Implants |
王云兵 Yunbing WANG | |
|
08:40-09:00 |
多功能两性离子抗凝血材料：机制、设计与应用 Multifunctional Zwitterionic Anticoagulant Materials: Mechanisms, Design, and Applications |
程钢 Gang CHENG | |
|
09:00-09:20 |
脱细胞组织工程可植入医疗器械及其空间医学前瞻性测试 Decellularized Tissue Engineering Implantable Medical Device and Its Forward-Looking Test for Space Medicine |
Dongan WANG | |
|
09:20-09:40 |
多孔结构微针装置的生物医学应用开发 Development of Microneedle Devices with Porous Structure for Biomedical Application |
Chenjie XU | |
|
09:40-10:00 |
结构性心脏病介入治疗创新技术 Innovations in Structural Heart Interventions |
Sanjeev Bhatt | |
Device Innovation Forum-2
|
10:20-12:00 北辰 竹风厅 |
|---|
| 主持 Moderators | 计剑 Jian JI, 王云兵 Yunbing WANG, 程钢 Gang CHENG, 陈兵 Bing CHEN | ||
|
10:20-10:40 |
⽣物3D打印：从器官模型构建到器官体外再造 Bioprinting: From Construction of Organ Models to In Vitro Organ Re-creation |
贺永 Yong HE | |
|
10:40-11:00 |
血管支架的功能创新一从时序功能性到再生修复性 Functional Innovation of Vascular Stents: From Temporal Functionality to Regenerative Repair |
黄楠 Nan HUANG | |
|
11:00-11:20 |
可降解医用锌合金的腐蚀降解行为及其在血管支架领域的应用研究 The Biodegradation Mechanism and In Vivo Performance of Zinc-based Vascular Stents |
牛佳林 Jialin NIU | |
|
11:20-11:40 |
铁基可吸收⽀架的临床进展 Clinical Progress of Iron-Based Bioresorbable Scaffolds |
宋雷 Lei SONG | |
|
11:40-12:00 |
⽣物型⼈⼯⾎管移植物动静脉内瘘FIM研究 First-in-Man (FIM) Study of a Biological Artificial Blood Vessel Graft for Arteriovenous Fistula |
祝成 Cheng ZHU | |
Frontiers in Blood Lipids and Arteriosclerosis Forum-1
|
13:30-15:30 北辰 竹风厅 |
|---|
| 主持 Moderators | 唐熠达 Yida TANG, 李建平 Jianping LI, 季晓平 Xiaoping JI, 谢小洁 Xiaojie XIE | ||
|
13:30-13:50 |
替代性LDL胆固醇降低策略对比高强度他汀类药物在ASCVD中的应用 Alternative LDL Cholesterol–Lowering Strategy vs High-Intensity Statins in ASCVD |
Myeong-Ki HONG | |
|
13:50-14:10 |
Obicetrapib在动脉粥样硬化性心血管疾病中的疗效与安全性 Efficacy and Safety of Obicetrapib in ASCVD |
陈桢玥 Zhenyue CHEN | |
|
14:10-14:30 |
脂蛋白(a)：证据、推荐与新兴疗法 Lipoprotein(a): Evidence, Recommendations, and Emerging Therapies |
Nathan WONG | |
|
14:30-14:50 |
ASCVD二级预防LDL-C目标阈值的新思考 New Thought of LDL-cholesterol Target for the Secondary Prevention in ASCVD |
李建军 Jianjun LI | |
|
14:50-15:10 |
原纤维蛋白-1在主动脉瘤与主动脉夹层形成中的复杂作用机制 The Complex Role of Fibrillin-1 in Development of Aortic Aneurysm and Dissection |
Alan DAUGHERTY | |
|
15:10-15:30 |
讨论 Discussion |
||
Frontiers in Blood Lipids and Arteriosclerosis Forum-2
|
15:30-17:30 北辰 竹风厅 |
|---|
| 主持 Moderators | 郭彩霞 Caixia GUO, Myeong-Ki HONG, 陈桢玥 Zhenyue CHEN, 彭道泉 Daoquan PENG, 郑超 Chao ZHENG | ||
|
15:30-15:50 |
冠心病抗炎治疗临床研究进展 Clinical Research Progress on Anti-inflammatory Therapy for Coronary Heart Disease |
程翔 Xiang CHENG | |
|
15:50-16:10 |
中国高胆固醇血症筛查与风险管控 An Approach to Hypercholesterolemia in China: Screening andRisk Management |
李建平 Jianping LI | |
|
16:10-16:30 |
降脂治疗前沿进展 Frontiers in Lipid-Lowering Therapy |
陈纪言 Jiyan CHEN | |
|
16:30-16:50 |
SGLT2i in Dyslipidemia | 郑超 Chao ZHENG | |
|
16:50-17:10 |
以ANGPTL3为靶点治疗混合型高脂血症 Targeting ANGPTL3 for Mixed Hyperlipidemia |
谢小洁 Xiaojie XIE | |
|
17:10-17:30 |
讨论 Discussion |
||
Lipid Forum-6
|
08:00-10:00 北辰 竹风厅 |
|---|
| 主持 Moderators | 邱原刚 Yuangang QIU, 周鹏 Peng ZHOU, 陈晓曙 Xiaoshu CHEN, 李国栋 Guodong LI, 钟海江 Haijiang ZHONG, 章瑾瑜 Jinyu ZHANG | ||
|
08:00-08:20 |
Pcsk9i降脂治疗低反应与LDL-R受体变异 Low Response to PCSK9i Lipid-Lowering Therapy and LDL-R Receptor Variation |
张钲 Zheng ZHANG | |
|
08:20-08:40 |
高甘油三酯血症的现状与管理新策略 Current Status and New Management Strategies of Hypertriglyceridemia |
傅国胜 Guosheng FU | |
|
08:40-09:00 |
心血管风险极高危患者联合降脂治疗策略 Combined Lipid-Lowering Therapy Strategy for Patients at Extremely High Cardiovascular Risk |
白锋 Feng BAI | |
|
09:00-09:20 |
“他汀不耐受的临床诊断与处理中国专家共识”解读 Interpretation of the “Chinese Expert Consensus on Clinical Diagnosis and Management of Statin Intolerance” |
赵兴胜 Xingsheng ZHAO | |
|
09:20-09:40 |
高血压患者的血脂管理策略 Lipid Management Strategy for Hypertensive Patients |
张新军 Xinjun ZHANG | |
|
09:40-10:00 |
2025 ESC/EAS血脂管理指南 重点更新 Key Updates of the 2025 ESC/EAS Guidelines for Lipid Management |
于汇民 Huimin YU | |
Lipid Forum-7
|
10:00-12:00 北辰 竹风厅 |
|---|
| 主持 Moderators | 谢峻 Jun XIE, 陈国雄 Guoxiong CHEN, 陈铁龙 Tielong CHEN, 沈剑耀 Jianyao SHEN, 季晓君 Xiaojun JI | ||
|
10:00-10:20 |
诊室外血压测量进展 Progress in Out-of-Clinic Blood Pressure Measurement |
陈晓平 Xiaoping CHEN | |
|
10:20-10:40 |
后他汀时代的血脂管理新策略：从残余风险控制到精准治疗 New Lipid Management Strategies in the Post-Statin Era: From Residual Risk Control to Precision Treatment |
柴大军 Dajun CHAI | |
|
10:40-11:00 |
鱼油的多靶点效应与糖尿病人群心血管获益的相关性再探讨 Re-exploration of the Correlation Between the Multi-Target Effect of Fish Oil and Cardiovascular Benefits in Diabetic Population |
王长谦 Changqian WANG | |
|
11:00-11:20 |
应激损伤与心血管风险认识与策略 Understanding and Strategy of Stress Injury and Cardiovascular Risk |
刘梅颜 Meiyan LIU | |
|
11:20-11:40 |
APOC3靶向降脂药物新突破 Emerging Frontiers in APOC3-Targeted Lipid-Lowering Therapy |
高秀芳 Xiufang GAO | |
|
11:40-12:00 |
血脂药物最新研究进展解读 Interpretation of the Latest Research Progress of Lipid-Lowering Drugs |
常静 Jing CHANG | |